Brian S Posner
Director, Dyne Therapeutics, Inc.; Director, Arch Capital Group
Bought, 12 months
$0.3M
Sold, 12 months
$0.1M
Companies
2
Latest trade
Oct 2, 2026
Companies
Dyne Therapeutics, Inc.Director +$0.3M Arch Capital GroupDirector −$0.1MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

